HALISTER: Amgen and UCB’s Osteoporosis Drug Bests Lilly’s Forteo in Study

Amgen and UCB’s Osteoporosis Drug Bests Lilly’s Forteo in Study

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
LLY US (Eli Lilly & Co)
AMGN US (Amgen Inc)
MRK US (Merck & Co Inc)
UCB BB (UCB SA)

People
Jan De Kerpel (KBC Groep NV)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283